4//SEC Filing
Biondi Paul 4
Accession 0000899243-23-016412
CIK 0001609809other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 5:35 PM ET
Size
5.4 KB
Accession
0000899243-23-016412
Insider Transaction Report
Form 4
Biondi Paul
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-22+35,000→ 35,000 totalExercise: $5.46Exp: 2033-06-21→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 22, 2024 or the day immediately prior to the company's 2024 annual meeting of shareholders.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001744508
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 5:35 PM ET
- Size
- 5.4 KB